Patents by Inventor Jerry Anthony Murry

Jerry Anthony Murry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of preparing inhibitors phosphodiesterase-4
    Patent number: 7312334
    Abstract: In one aspect, the present invention is directed to a one pot method of preparing intermediates of Formula (V), which are useful in making inhibitors of phosphodiesterase-4: The present invention is also directed to a method of preparing phosphodiesterase inhibitors comprising the Formula (IX, IXa).
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: December 25, 2007
    Assignee: Merck & Co. Inc.
    Inventors: Jennifer Albaneze-Walker, Jerry Anthony Murry, Arash Soheili, Shawn A. Springfield
  • Method of preparing inhibitors of phosphodiesterase-4
    Patent number: 6909002
    Abstract: In one aspect, the present invention is directed to a one pot method of preparing intermediates of Formula V, which are useful in making inhibitors of phosphodiesterase-4: The present invention is also directed to a method of preparing phosphodiesterase inhibitors comprising the Formula
    Type: Grant
    Filed: October 21, 2003
    Date of Patent: June 21, 2005
    Assignee: Merck & Co., Inc.
    Inventors: Jennifer Albaneze-Walker, Scott Ceglia, Jerry Anthony Murry, Arash Soheili
  • Method of preparing inhibitors of phosphodiesterase-4
    Publication number: 20040102472
    Abstract: In one aspect, the present invention is directed to a one pot method of preparing intermediates of Formula V, which are useful in making inhibitors of phosphodiesterase-4: 1
    Type: Application
    Filed: October 21, 2003
    Publication date: May 27, 2004
    Inventors: Jennifer Albaneze-Walker, Scott Ceglia, Jerry Anthony Murry, Arash Soheili
  • Tartrate salt of a substituted dipeptide as growth hormone secretagogue
    Patent number: 6596867
    Abstract: This application relates to processes for making compounds of formula I, and processes for making intermediates useful in the processes for making compounds of formula I.
    Type: Grant
    Filed: December 11, 2000
    Date of Patent: July 22, 2003
    Assignee: Pfizer Inc.
    Inventors: Philip Albert Carpino, Paul Andrew Dasilva-Jardine, Bruce Allen Lefker, Jerry Anthony Murry
  • Synthesis of acylated keto amides from sulfonyl amides
    Publication number: 20030083503
    Abstract: Acylated ketoamides are prepared from sulfonyl amides and aldehydes or their related derivatives by a step of 1
    Type: Application
    Filed: June 20, 2002
    Publication date: May 1, 2003
    Inventors: Doug E. Frantz, Lisa F. Frey, Karen Marcantonio, Jerry Anthony Murry, Richard Tillyer
  • Tartrate salt of a substituded dipeptide as growth hormone secretagogue
    Publication number: 20010016570
    Abstract: This invention is directed to the (L)-tartaric acid salt of 2-amino-N-{1 -(R)-(2,4-difluoro-benzyloxymethyl)-2-oxo-2-[3-oxo-3a-(R)-pyridin-2-ylmethyl-2-(2,2,2-trifluoroethyl)-2,3,3a,4,6,7-hexahydro-pyrazolo[4,3-c]pyridin-5-yl]-ethyl}-2-methyl-propionamide which is a growth hormone secretagogue and as such is useful for increasing the level of endogenous growth hormone. In another aspect, this invention provides certain intermediates which are useful in the synthesis of the foregoing compound. The (L)-tartaric acid salt of the compound of this invention is useful for the treatment and/or prevention of osteoporosis, insulin resistance and other conditions or diseases associated with growth hormone deficiency.
    Type: Application
    Filed: December 11, 2000
    Publication date: August 23, 2001
    Inventors: Philip Albert Carpino, Paul Andrew Dasilva-Jardine, Bruce Allen Lefker, Jerry Anthony Murry
  • Tartrate salt of a substituted dipeptide as growth hormone secretagogue
    Patent number: 6248717
    Abstract: This invention is directed to the (L)-tartaric acid salt of 2-amino-N-{1-(2,4-difluoro-benzyloxymethyl)-2-oxo-2-[3-oxo-3a-pyridin-2-ylmethyl-2-(2,2,2-trifluoro-ethyl)-2,3,3a,4,6,7-hexahydro-pyrazolo{4,3-c}pyridin-5-yl]-ethyl]-2-methyl-propionamide which is a growth hormone secretagogue and as such is useful for increasing the level of endogenous growth hormone. In another aspect this invention provides certain intermediates which are useful in the synthesis of the foregoing compound. The (L)-tartaric acid salt of the compound of this invention is useful in the treatment and/or prevention of osteoporosis, insulin resistance and other conditions or diseases associated with growth hormone deficiency. The (L)-tartaric acid salt of the compound of the present invention is also useful in treating osteoporosis when used in combination with: a bisphosphonate compound; estrogen, Premarin, and optionally progesterone; an estrogen agonist or antagonist; or calcitonin.
    Type: Grant
    Filed: September 7, 1999
    Date of Patent: June 19, 2001
    Assignee: Pfizer Inc.
    Inventors: Philip Albert Carpino, Paul Andrew Dasilva-Jardine, Bruce Allen Lefker, Jerry Anthony Murry